HIF stabilizers in the management of renal anemia: from bench to bedside to pediatrics
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIF stabilizers in the management of renal anemia: from bench to bedside to pediatrics
Authors
Keywords
Anemia, Chronic kidney disease, HIF stabilizer, HIF prolyl-hydroxylase inhibitor
Journal
PEDIATRIC NEPHROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-03-22
DOI
10.1007/s00467-017-3849-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis
- (2017) Michelle N. Rheault et al. KIDNEY INTERNATIONAL
- Hemoglobin target in children with chronic kidney disease: valuable new information
- (2017) Motoshi Hattori KIDNEY INTERNATIONAL
- Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China
- (2017) Nan Chen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
- (2016) Robert Provenzano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
- (2016) R. Provenzano et al. Clinical Journal of the American Society of Nephrology
- Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?
- (2016) Farhanah Yousaf et al. CURRENT HYPERTENSION REPORTS
- Peginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise
- (2016) Terhi Hermanson et al. Expert Opinion On Drug Safety
- Neurocognitive, Social-Behavioral, and Adaptive Functioning in Preschool Children with Mild to Moderate Kidney Disease
- (2016) Stephen R. Hooper et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Increased Synthesis of Liver Erythropoietin with CKD
- (2016) S. de Seigneux et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease
- (2016) Pablo E. Pergola et al. KIDNEY INTERNATIONAL
- The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice
- (2016) Pinelopi P. Kapitsinou et al. MOLECULAR AND CELLULAR BIOLOGY
- SO036MOLIDUSTAT INCREASES HAEMOGLOBIN IN ERYTHROPOIESIS STIMULATING AGENTS (ESA)-NAIVE ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS (CKD-ND)
- (2016) Iain C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Regulates Chondrocyte Differentiation and Secondary Ossification in Mice
- (2016) Shaohong Cheng et al. Scientific Reports
- Long-Term Risk of Cancer in Survivors of Pediatric ESRD
- (2015) S. Ploos van Amstel et al. Clinical Journal of the American Society of Nephrology
- Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia
- (2015) L. Holdstock et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients
- (2015) A. Besarab et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
- (2015) Anatole Besarab et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Roles of renal erythropoietin-producing (REP) cells in the maintenance of systemic oxygen homeostasis
- (2015) Norio Suzuki et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Identification of erythroferrone as an erythroid regulator of iron metabolism
- (2014) Léon Kautz et al. NATURE GENETICS
- Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS)
- (2014) Iain C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis
- (2014) Rachel M. Lestz et al. PEDIATRIC NEPHROLOGY
- Inhibition of Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Oxygen Sensors: Tricking the Body into Mounting Orchestrated Survival and Repair Responses
- (2013) Michael H. Rabinowitz JOURNAL OF MEDICINAL CHEMISTRY
- Plasticity of Renal Erythropoietin-Producing Cells Governs Fibrosis
- (2013) T. Souma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Management of Anemia in Children Receiving Chronic Peritoneal Dialysis
- (2013) D. Borzych-Duzalka et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival
- (2013) Juan C Scornik et al. BMC Nephrology
- Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
- (2012) Ioannis Koulouridis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatments
- (2012) Wolfgang Jelkmann EXPERT OPINION ON BIOLOGICAL THERAPY
- Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis
- (2012) Qingdu Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- The consequences of chronic kidney disease on bone metabolism and growth in children
- (2012) J. Bacchetta et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Notice
- (2012) Kidney International Supplements
- Hypoxia-Inducible Factor-2α Mediates the Adaptive Increase of Intestinal Ferroportin During Iron Deficiency in Mice
- (2011) Matthew Taylor et al. GASTROENTEROLOGY
- Intestinal Hypoxia-inducible Factor-2α (HIF-2α) Is Critical for Efficient Erythropoiesis
- (2011) Erik R. Anderson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of erythropoietin production
- (2010) Wolfgang Jelkmann JOURNAL OF PHYSIOLOGY-LONDON
- Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
- (2010) W. M. Bernhardt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS
- (2010) Meredith A. Atkinson et al. PEDIATRIC NEPHROLOGY
- Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
- (2009) Kamyar Kalantar-Zadeh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Repression via the GATA box is essential for tissue-specific erythropoietin gene expression
- (2008) N. Obara et al. BLOOD
- Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2 mutation
- (2008) D. P. Gale et al. BLOOD
- Biology of HIF-1α
- (2008) A Weidemann et al. CELL DEATH AND DIFFERENTIATION
- Anemia and Risk of Hospitalization in Pediatric Chronic Kidney Disease
- (2008) A. O. Staples et al. Clinical Journal of the American Society of Nephrology
- Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin
- (2008) T. Kapoian et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
- (2008) William G. Kaelin et al. MOLECULAR CELL
- Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts
- (2008) Oluwatoyin Fatai Bamgbola et al. PEDIATRIC NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More